2 healthcare shares to pounce on at a lower price

Credit: Brogan & Partners

With Australian shares looking so expensive that one fund manager reportedly sold all his investments and returned the money to investors, it’s no wonder some Australians are getting nervous about the share market.

Still, it never hurts to have a few companies in mind that you’d pounce on in the event of a market crash. Here are two I’d buy in a flash if they were cheaper:

CSL Limited (ASX: CSL)

CSL Limited produces life-saving blood products for customers with rare diseases worldwide. It generates oodles of cash from its sales, which it reinvests into research & development, acquiring new businesses, and buying back shares. CSL recently bought the Seqirus vaccine business, which is currently unprofitable but expected to become a significant contributor to earnings in the next couple of years.

The company also has several promising treatments in the later stages of development which, if successful, could generate new earnings streams for years into the future. The main drawback is price, but I would start to get pretty interested in CSL below $100.

Fisher & Paykel Healthcare Corp Ltd (ASX: FPH)

Fisher & Paykel designs and manufactures oxygen masks, humidifiers, and other types of breathing equipment and consumables for use in hospitals. It’s rapidly expanded its operations over the past few years and has delivered stellar results for investors. Now, the company is increasingly migrating its manufacturing to Mexico, which is expected to reduce costs and improve profitability.

The company also has an active research & development team, and spends a similar percentage of revenue to CSL (10%) on its R&D every year. New products have been significant contributors to earnings growth so far, and there are more in the works. Again price is an issue, but I’d be quite interested in Fisher & Paykel around $8.

In the meantime, these 3 dividend stocks look attractively priced today, in my opinion:

Top 3 ASX Blue Chips To Buy In 2017

For many, blue chip stocks means stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool's in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool's Top 3 Blue Chip Stocks for 2017."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

If you're expecting to see the likes of Commonwealth Bank, Telstra and Wesfarmers shares on this list, you'll be sorely disappointed. Not only are their dividends growing at a snail's pace, their profits are under pressure too due to the increasing competitive environment.

The contrast to these "new breed" blue chips couldn't be greater... especially the very real prospect of significant share price gains, something that's looking less likely from the usual blue chip suspects.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand - and how quickly the share prices of these companies moves - we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor Sean O'Neill has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.